Jazz Pharmaceuticals plc
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2019
Total Assets: $5.54B
Liabilities Breakdown FY2019
Total Liabilities: $2.43B
Asset Breakdown
Total Assets: $5.54B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $637.3M | 11.5% |
| Accounts Receivable | $356.0M | 6.4% |
| Inventory | $78.6M | 1.4% |
| Property, Plant & Equipment | $131.5M | 2.4% |
| Goodwill | $920.0M | 16.6% |
| Intangible Assets | $2.44B | 44.1% |
| Other Assets | $974.5M | 17.6% |
Liabilities Breakdown
Total Liabilities: $2.43B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $45.7M | 1.9% |
| Long-Term Debt | $1.57B | 64.8% |
| Other Liabilities | $808.3M | 33.3% |